BioMarin Pharmaceutical Inc.
GB ˙ LSE ˙ US09061G1013
54,65 $ ↑0,60 (1,11%)
2026-06-03
DEL PRIS
SecurityGB:0HNC / BioMarin Pharmaceutical Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership1,496,852 shares
Latest Disclosed Value $ 84,557,169
UBS Group AG ownership in 0HNC / BioMarin Pharmaceutical Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,496,852 shares of BioMarin Pharmaceutical Inc. (GB:0HNC) valued at $83,374,656 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 2,211,721 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -32.32% during the quarter. The current value of the position is $81,802,962 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (0HNC) in the form of stock options. The firm currently holds call options representing 140,700 of underlying shares valued at $7,948,143 USD and put options representing 285,500 of underlying shares valued at $16,127,895 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0HNC / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,496,852 -714,869 -32.32 84,557 -35.67 0.0127
2026-01-29 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,211,721 671,551 43.60 131,443 57.58 0.0213
2025-11-13 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,540,170 -155,423 -9.17 83,416 -10.50 0.0131
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,695,593 1,579 0.09 93,207 -22.17 0.0161
2025-05-13 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,694,014 185,381 12.29 119,750 20.76 0.0220
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,508,633 646,662 75.02 99,162 63.67 0.0183
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 861,971 476,429 123.57 60,588 90.88 0.0132
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 385,542 -4,670,897 -92.38 31,742 -92.81 0.0078
2024-05-13 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,056,439 4,963,987 5,369.26 441,629 4,854.33 0.1100
2024-02-09 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 92,452 -152,805 -62.30 8,914 -58.92 0.0027
2023-11-09 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 245,257 -24,719 -9.16 21,700 -7.27 0.0075
2023-08-11 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 269,976 74,431 38.06 23,402 23.07 0.0079
2023-05-12 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 195,545 -471,739 -70.70 19,015 -72.47 0.0069
2023-02-08 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 667,284 -437,947 -39.62 69,057 -26.29 0.0258
2022-11-10 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,105,231 -1,588,293 -58.97 93,690 -58.03 0.0411
2022-08-10 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,693,524 -167,979 -5.87 223,212 1.17 0.0917
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,861,503 2,697,524 1,645.04 220,623 1,422.90 0.0736
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 163,979 -133,514 -44.88 14,487 -36.99 0.0041
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 297,493 153,667 106.84 22,993 91.59 0.0072
2021-08-13 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 143,826 -51,512 -26.37 12,001 -18.64 0.0039
2021-05-12 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 195,338 65,250 50.16 14,750 29.30 0.0049
2021-02-11 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 130,088 45,648 54.06 11,408 77.58 0.0039
2020-11-12 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 84,440 -40,207 -32.26 6,424 -58.22 0.0024
2020-07-31 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 124,647 6,674 5.66 15,375 54.23 0.0065
2020-05-01 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 117,973 -26,296 -18.23 9,969 -18.27 0.0047
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 144,269 -153,846 -51.61 12,198 -39.29 0.0042
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 298,115 149,236 100.24 20,093 57.58 0.0077
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 148,879 -19,346 -11.50 12,751 -14.67 0.0049
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 168,225 9,054 5.69 14,943 10.26 0.0062
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 159,171 -11,649 -6.82 13,553 -18.18 0.0061
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 170,820 55,475 48.09 16,565 52.46 0.0066
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 115,345 -129,186 -52.83 10,865 -45.20 0.0047
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 244,531 64,143 35.56 19,825 23.24 0.0086
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 180,388 24,825 15.96 16,086 11.11 0.0066
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 155,563 -24,469 -13.59 14,478 -11.45 0.0067
2017-11-14 2017-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 180,032 20,636 12.95 16,350 16.85 0.0085
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 180,032 20,636 16,350
2017-11-14 2017-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 159,396 -72,736 -31.33 13,992 -27.24 0.0076
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 159,396 -72,736 13,992
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 232,132 -71,543 -23.56 19,230 -31.56 0.0106
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 303,675 131,344 76.22 28,096 109.56 0.0167
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 172,331 10,717 6.63 13,407 0.58 0.0084
2016-05-12 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 161,614 5,160 3.30 13,330 -18.67 0.0089
2016-02-16 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 156,454 -49,311 -23.96 16,390 -24.37 0.0106
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 205,765 -29,515 -12.54 21,671 -32.66 0.0153
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 235,280 -35,720 -13.18 32,182 -4.71 0.0214
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 271,000 123,000 83.11 33,772 152.43 0.0233
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 148,000 148,000 13,379 0.0094
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 140,700 -16.55 7,948 -20.67 n/a n/a n/a
2026-01-29 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 168,600 1,956.10 10,020 2,156.53 n/a n/a n/a
2025-11-13 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 8,200 -67.72 444 -68.19 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 25,400 111.67 1,396 64.62 n/a n/a n/a
2025-05-13 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 12,000 60.00 848 72.36 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 7,500 -42.31 493 -46.11 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 13,000 73.33 914 47.97 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 7,500 0.00 617 -5.80 n/a n/a n/a
2024-05-13 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 7,500 655 n/a n/a n/a
2023-11-09 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-11 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 17,500 1,517 n/a n/a n/a
2023-02-08 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-10 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 68,272 5,787 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-13 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 20,000 1,669 n/a n/a n/a
2021-02-11 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-12 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 260 -99.13 20 -99.46 n/a n/a n/a
2020-07-31 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 30,000 18.76 3,700 73.38 n/a n/a n/a
2020-05-01 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 25,260 -20.82 2,134 -20.88 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 31,900 27.60 2,697 60.06 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 25,000 -21.63 1,685 -37.52 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 250 22 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 800 166.67 75 212.50 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 300 -97.91 24 -98.12 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 14,332 -41.07 1,278 -43.53 n/a n/a n/a
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 24,320 69.69 2,263 77.07 n/a n/a n/a
2017-11-14 2017-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 300 -61.59 26 -60.00 n/a n/a n/a
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 300 26 n/a n/a n/a
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 781 -99.22 65 -99.30 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 100,481 33,393.67 9,297 40,321.74 n/a n/a n/a
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 300 -99.70 23 -99.75 n/a n/a n/a
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 38,800 104.21 5,307 124.11 n/a n/a n/a
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 19,000 2,275.00 2,368 3,188.89 n/a n/a n/a
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 800 72 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 285,500 606.68 16,128 571.96 n/a n/a n/a
2026-01-29 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 40,400 210.77 2,401 240.91 n/a n/a n/a
2025-11-13 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 13,000 -7.14 704 -8.45 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 14,000 1,300.00 770 998.57 n/a n/a n/a
2025-05-13 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 1,000 -86.67 71 -85.77 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 7,500 -83.77 493 -84.85 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 46,200 516.00 3,247 426.26 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 7,500 0.00 617 -5.80 n/a n/a n/a
2024-05-13 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 7,500 655 n/a n/a n/a
2023-11-09 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-11 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 9,600 832 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 20,000 -21.57 1,767 -10.35 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 25,500 -71.95 1,971 -74.01 n/a n/a n/a
2021-08-13 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 90,900 179.69 7,585 209.09 n/a n/a n/a
2021-05-12 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 32,500 225.00 2,454 179.82 n/a n/a n/a
2021-02-11 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 10,000 0.00 877 15.24 n/a n/a n/a
2020-11-12 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 10,000 0.00 761 -13.23 n/a n/a n/a
2020-07-31 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-01 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 33,500 -33.00 2,831 -33.04 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 50,000 -33.33 4,228 -16.36 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 75,000 36.36 5,055 7.30 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 55,000 1,427.78 4,711 1,372.19 n/a n/a n/a
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 3,600 -93.45 320 -93.21 n/a n/a n/a
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 2,500 231 n/a n/a n/a
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 100 0.00 12 33.33 n/a n/a n/a
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 100 9 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.